August 2, 2024
Huntington Beach, California
Meet our Senior Vice President & Global Head of Biometrics, Abie Ekangaki, Ph.D, who will be presenting on InSilico designs in drug development.
A Path to Acceleration using In Silico Methods in Drug Development
August 2, 2024, 12:30 – 1:30 pm PT
Program Synopsis & Learning Objectives:
- Recognize those challenges of clinical trials that justify use of digital patients in trials for regulatory approval of new treatments.
- Understand the general framework for constructing in silico synthetic patients for use as control arm of clinical trials.
- Insights on recently published and evolving guidelines for in silico modeling and simulation necessary to ensure credibility of these approaches for regulatory submission.